Despite operational strength, SYK trades at a significant valuation premium to sector peers, with a PEG ratio above 2 and ...

Stryker is flat since the beginning of the year, and at $357.78 per share, it is trading 11.3% below its 52-week high of $403 ...

Stryker continues to deliver strong organic growth, having posted organic growth rates of around 10% for a long period of time now. Learn more about SYK stock here.

Stryker on Thursday raised the lower end of its full-year profit forecast after beating estimates for third-quarter earnings, banking on strong demand for its medical and surgical devices.

The medical products maker now expects sales to grow 9.8% to 10.2% in the full year.

Medical technology company Stryker (NYSE:SYK) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.2% year on year to $6.06 billion. Its non-GAAP profit of $3.19 per share was 1.9% ...

Analysts have recently evaluated Stryker and provided 12-month price targets. The average target is $417.57, accompanied by a ...

Stryker (SYK) delivered earnings and revenue surprises of +1.59% and +0.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Stryker (SYK) reported current net profit margins of 12.1%, a step down from last year’s 16.3%, with the latest results ...

Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Reported net sales increased 10.3% to $6.1 billion Organic net sales ...